Key result
Traditional Chinese medicine targets mitochondrial dysfunction and cell death in peripheral ischemia-reperfusion injury.
Answers are grounded in this paper and cite their sources.
Peripheral artery disease (PAD) is a serious public health issue, characterized by circulation disorder of the lower extreme that reduces the physical activity of the lower extremity muscle. The artery narrowed by atherosclerotic lesions initiates limb ischemia. In the progression of treatment, reperfusion injury is still inevitable. Ischemia-reperfusion injury induced by PAD is responsible for hypoxia and nutrient deficiency. PAD triggers hindlimb ischemia and reperfusion (I/R) cycles through various mechanisms, mainly including mitochondrial dysfunction and inflammation. Alternatively, mitochondrial dysfunction plays a central role. The I/R injury may cause cells' injury and even death. However, the mechanism of I/R injury and the way of cell damage or death are still unclear. We review the pathophysiology of I/R injury, which is majorly about mitochondrial dysfunction. Then, we focus on the cell damage and death during I/R injury. Further comprehension of the progress of I/R will help identify biomarkers for diagnosis and therapeutic targets to PAD. In addition, traditional Chinese medicine has played an important role in the treatment of I/R injury, and we will make a brief introduction.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2021) conducted a review in Ischemia-reperfusion injury in peripheral artery disease. Traditional Chinese medicine was evaluated. Traditional Chinese medicine is reviewed for treating ischemia-reperfusion injury in peripheral artery disease, focusing on mitochondrial dysfunction and cell death (no quantitative data reported).
Synapse has enriched 10 related papers. Consider them for comparative context: